Certified by Founder Lodge
Lilly Asia Ventures 礼来亚洲基金
China - Shanghai
INVESTOR
1 Disclosed Funding Rounds $200,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
N/A
Company | Date | Round | Raised |
---|---|---|---|
ADARx Pharmaceuticals Inc. | August, 10 ,2023 | Series C | $200,000,000 |
Lynk Pharmaceuticals | September, 22 ,2023 | Series C | |
Akura Medical | October, 04 ,2023 | Series B | $35,000,000 |